1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends

Global Dyslipidemia Drugs Market 2017-2021

  • March 2017
  • 70 pages
  • Infiniti Research Limited
Report ID: 4796707

Summary

Table of Contents

Search Inside

About Dyslipidemia Drugs

Lipid refers to fat comprising proteins and carbohydrates. Cholesterol and triglycerides are lipids that are stored in the human body and serve as a source of energy. Dyslipidaemia is the imbalance in the lipid level in the bloodstream. It is characterized by high levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C) in the blood. High cholesterol levels can cause cardiovascular diseases (CVD) such as stroke and atherosclerosis. The typical range of total blood cholesterol is 140-200 mg/dL. Blood cholesterol contains individual components such as LDL-C and high-density lipoprotein cholesterol (HDL-C). Low-density lipoprotein (LDL) carries cholesterol to the body while high-density lipoprotein (HDL) removes cholesterol from the cells by reversing cholesterol transport to the liver. Due to their distinct roles, these components are individually assessed to determine the dyslipidemic status of an individual.

Technavio’s analysts forecast the global dyslipidemia drugs market to grow at a CAGR of 5.27% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global dyslipidemia drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Dyslipidemia Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- AstraZeneca
- Merck
- Pfizer
- Sanofi

Other prominent vendors
- Alnylam Pharmaceuticals
- Amarin Corporation
- Amgen
- Bristol-Myers Squibb
- Catabasis Pharmaceuticals
- Cerenis
- Cipla
- CJ HealthCare
- CKD Bio
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Eli Lilly
- Esperion Therapeutics
- GlaxoSmithKline
- JW Pharmaceuticals
- Kadmon Pharmaceuticals
- Lupin Pharmaceuticals

Market driver
- Change in ATP guidelines for management of hypercholesterolemia.
- For a full, detailed list, view our report

Market challenge
- Drawbacks associated with current therapies.
- For a full, detailed list, view our report

Market trend
- Increased uptake of OTC drugs.
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Methodology
Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Dyslipidemia Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Dyslipidemia Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Dyslipidemia Global Clinical Trials Review, H2, 2017" provides an overview of Dyslipidemia clinical ...

Cholesterol Test Volume and Sales Forecasts 2021: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

  • $ 750
  • Industry report
  • September 2017
  • by Venture Planning Group

This new report from LeadingMarketResearch provides analysis of Cholesterol testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts ...

HDL Cholesterol Test Volume and Sales Forecasts 2021: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

  • $ 750
  • Industry report
  • September 2017
  • by Venture Planning Group

This new report from LeadingMarketResearch provides analysis of HDL Cholesterol testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.